Currently out of the existing stock ratings of William Quirk, 149 are a BUY (70.28%), 58 are a HOLD (27.36%), 5 are a SELL (2.36%).

William Quirk

Work Performance Price Targets & Ratings Chart

Analyst William Quirk, carries an average stock price target met ratio of 88.17% that have a potential upside of 24.28% achieved within 263 days. Previously, William Quirk worked at PIPER SANDLER.

William Quirk’s has documented 447 price targets and ratings displayed on 27 stocks. The coverage was on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 10-Nov-2023.

Wall Street Analyst William Quirk

Analyst best performing recommendations are on FLGT (FULGENT GENETICS).
The best stock recommendation documented was for FLGT (FULGENT GENETICS) at 11/5/2019. The price target of $12.3 was fulfilled within 1 day with a profit of $0.71 (5.46%) receiving and performance score of 54.57.

Average potential price target upside

of $47.53 (21.97%) on ILMN (ILLUMINA).
of $42.59 (30.78%) on AXDX (ACCELERATE DIAGNOSTICS).
of $41.23 (23.11%) on BDX (BECTON DICKINSON AND COMPANY).

AVTR Avantor AXDX Accelerate Diagnostics BDX Becton Dickinson and Company CDNA Caredx FLDM Fluidigm FLGT Fulgent Genetics HOLX Hologic LH Laboratory of America Holdings LMNX Luminex MASI Masimo MYGN Myriad Genetics OCX OncoCyte Corp PACB Pacific Biosciences of California PKI PerkinElmer GHDX Genomic Health ILMN Illumina DGX Quest Diagnostics NTRA Natera QGEN Qiagen NV EW Edwards Lifesciences Corp QDEL Quidel OXFD Oxford Immunotec Global PLC A Agilent Technologies DHR Danaher HSKA Heska VCYT Veracyte VIVO Meridian Bioscience

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Alexei Gogolev (JPMORGAN)